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Doppler ultrasonographyAbstract Background: Angiopoietin-2 (Ang-2) is connected to angiogenesis in synovial regions,
but the signiﬁcance of its levels in patients with rheumatoid arthritis (RA) is still unclear.
Aim of the work: To evaluate the signiﬁcance of serum levels of Ang-2 in patients with RA. Also,
to determine Ang-2 relationship to the ﬁndings of joints Doppler ultrasonographic ﬁndings.
Patients and methods: This study included 40 patients with RA, and 25 matched healthy con-
trols. All patients were subjected to assessment of pain using visual analogue scale (VAS), assess-
ment of personal activity using the Health Assessment Questionnaire (HAQ) score, and
calculation of disease activity score (DAS 28). Laboratory assays of complete blood count
(CBC), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF)
titre, and measurement of serum levels of Ang-2 by ELISA. Doppler ultrasonography (US) assess-
ment for eight joints, with calculation of synovial thickness and total signal score (TSS), was done.
Results: Serum Ang-2 levels were signiﬁcantly higher among patients (3191.3 ± 594.9 pg/ml)
than controls (1771.7 ± 103.1 pg/ml) (p< 0.001). Serum Ang-2 levels were signiﬁcantly correlated
with ESR, CRP, DAS28, and duration of morning stiffness (p< 0.001, p< 0.001, p< 0.001, and
p= 0.025, respectively). There was a signiﬁcant correlation between serum Ang-2 levels and ﬁnd-
ings of US, regarding joint synovial thickness, and TSS (p< 0.001, for both).
Conclusion: Patients with RA had signiﬁcantly higher levels of serum Ang-2 versus controls. In
those patients, serum Ang-2 levels were signiﬁcantly correlated with disease activity markers (ESR,
16 S.G. Soliman et al.CRP), DAS28, and duration of morning stiffness. Moreover, these levels were signiﬁcantly corre-
lated with synovial thickness, and TSS. The role of Ang-2 in RA pathogenesis might open the door
to the development of new therapeutic strategies, particularly which target angiogenesis.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society for Joint Diseases and
Arthritis. Open access under CC BY-NC-ND license.1. Introduction
Rheumatoid arthritis (RA) is a disease characterized by the
chronic inﬂammation of joint synovial tissues. Inﬂammatory
synovial tissue is called pannus. At such sites, many newly
formed vessels are observed [1,2]. Angiogenesis is the forma-
tion of new capillaries from pre-existing blood vessels. Angio-
genesis has been associated with inﬂammation and chronic
inﬂammatory diseases, including RA [3,4].
Angiopoietin-2 (Ang-2), which is 478 amino acids in length
with a molecular weight of 70 KDa, is a glycoprotein, and an
angiogenic factor, plays an important role in the angiogenesis
of pannus [5]. It is expressed in endothelial cells, stored in ves-
icles, and is rapidly released in response to speciﬁc stimuli at
sites of vascular remodeling [6]. Ang-2 acts by binding to endo-
thelium speciﬁc receptor Tyrosine kinase-2 (Tie-2) and the
Ang/Tie system tightly controls the endothelial phenotype
during angiogenesis and vascular inﬂammation in a unique
fashion [7].
Doppler ultrasonography (US), which directly visualizes
the synovial-membrane vessels, provides very early informa-
tion on changes in synovitis activity during the course of
inﬂammatory joint disease [8,9]. Doppler US can assess the
synovial pannus and vascular tissues along with the detection
of low-velocity blood ﬂow at the microvascular level [10,11].
US is far more sensitive than physical examination for detect-
ing rheumatoid synovitis. Also, it has similar sensitivity to
magnetic resonance imaging, but is both far easier to use
and considerably less expensive [12,13].
Therefore, the aim of the current study was to estimate ser-
um levels of Ang-2 in patients with RA. Also, to correlate
these levels with various clinical and Doppler US parameters.
2. Patients and methods
This study included forty RA patients [36 (90%) were females,
and 4 (10%) were males], and their mean age was
43.9 ± 6.6 years. In addition, twenty ﬁve, age and sex matched
healthy volunteers, were included. They included 20 (80%) fe-
males, and 5 (20%) males, and their mean age was
44.2 ± 6.8 years.
All RA patients were attendants of the Rheumatology inpa-
tient or outpatient Department, Faculty of Medicine, Meno-
uﬁya University Hospital, in the period from September
2012 to May 2013.
Diagnosis of RA was made according to the American
Rheumatism Association (ARA) criteria of American College
of Rheumatology [14]. Patients with other suspected or known
collagenic disease, liver disease, or renal disease were excluded
from this study. The study was approved by our ethics com-
mittee of the faculty of medicine, and an informed consent
was taken from all subjects.All patients and controls were subjected to full history tak-
ing especially for duration of morning stiffness, fatigue and
HAQ score assessment; and clinical examination, particularly
for number of swollen joints, number of tender joints, and pa-
tient’s assessment of pain using visual analogue scale (VAS).
Moreover, disease activity score (DAS 28), was calculated
with assessment of swollen and tender joints using 28-Joint
counts [15].
Laboratory investigations included assays of complete
blood count (CBC), C-reactive protein (CRP), erythrocyte
sedimentation rate (ESR), rheumatoid factor (RF) titre, and
serum levels of Ang-2.
2.1. Sample collection and assay
7 ml of venous blood samples were collected from all subjects
under complete aseptic condition by clean venipuncture then
dispensed into three tubes: 3 ml into plain tubes for chemical
analysis of the previously mentioned parameters, 2 ml was
transferred into EDTA tubes for complete blood count and
1.6 ml of blood was transferred to a tube with 0.4 ml citrate
for ESR measurement. The samples in plane tubes, let to stand
to clot and serum was separated in aliquots after centrifuga-
tion and stored at 70 until analysis of the following materi-
als. CRP was determined using immunoassay [16]. RF
concentration was assessed using RF Latex which was a slide
agglutination test for the qualitative and semiquantitative
detection of RF in human serum. Latex particles coated
with human gammaglobulin were agglutinated when mixed
with samples which contain RF [17]. ESR was determined
according to Westergren method, and CBC was determined
using a pentra-80 automated blood counter (ABX-France,
Montpellier, France).
2.2. Ang-2 sample assay
It was assessed by The RayBio-Human Ang-2 Enzyme-
Linked Immunosorbent Assay (ELISA) kit, which was
in vitro enzyme-linked immunosorbent assay for the quanti-
tative measurement of human Ang-2 in the serum. This as-
say employed an antibody-speciﬁc for human Ang-2 coated
on a 96-well plate. Standards and samples were pipetted into
the wells and Ang-2 present in a sample was bound to the
wells by the immobilized antibody. The wells were washed
and biotinylated anti-human Ang-2 antibody was added.
After washing away unbound biotinylated antibody, HRP-
conjugated streptavidin was pipetted to the wells. The wells
were again washed, a TMB substrate solution is added to
the wells and colour develops in proportion to the amount
of Ang-2 bound. The Stop solution changes the colour from
blue to yellow, and the intensity of the colour is measured at
450 nm.
Table 1 Clinical and laboratory characteristics of rheumatoid
arthritis patients.
Patients (n= 40) Mean ±SD Range
Disease duration (years) 9.0 ± 6.4 2–20
Duration of MS (minutes) 45.5 ± 22.6 5–60
Number of swollen joints 4.6 ± 3.8 1–17
Number of tender joints 6.3 ± 3.9 1–17
Serum RF titre (IU/ml) 60.6 ± 68.5 12–356
VAS (cm) 5.3 ± 1.1 4–8
DAS 28 4.8 ± 0.7 3.8–6.2
HAQ 6.0 ± 2.9 4–14
MS=Morning stiffness, RF = Rheumatoid factor, VAS = Vi-
sual analogue scale, DAS28 = Disease activity score, HAQ=
Health Assessment Questionnaire.
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A Hitachi ultrasound system (Hitachi medical systems, Japan)
was used for the US examinations using a 15 MHz linear array
transducer. The target joint was scanned at predeﬁned trans-
ducer positions for that particular joint and the synovial mem-
brane was examined longitudinally and transversally. Blood
ﬂow in the synovial membrane was visualized with colour
Doppler US. The colour Doppler settings were the same for
all joints and all patients with a gain setting just below the
noise level using our set up for low ﬂow-Nyquist limit +/
0.014 m/s and 7 MHz Doppler frequency. With this set up
all the colour pixels in the image correspond to motion, that
is, blood ﬂow. Quantitative estimation of the vascularization
in the synovial membrane was performed using the selected
colour Doppler image (CDI) with maximum colour activity.
At present the colour Doppler is as sensitive as the power
Doppler on the Hitachi. The digitally stored CDI in DICOM
format was transferred to a processing programme. The syno-
vium was traced, indicating the region of interest (ROI). On
the US image the synovium appeared as a predominantly
hypoechoic mass covering the bony surfaces adjacent to the
joint. By using a colour recognition function the number of
colour pixels as well as the total number of pixels in the ROI
were counted [18]. The number of colour pixels was then ex-
pressed in relation to the total amount of pixels in the ROI
as the colour fraction. The total number of pixels (=synovial
area) was also noted separately, as an estimate of the synovial
membrane volume.
Tenosynovial and intrabursal pulsed Doppler (PD) signals
were graded on a semi-quantitative scale from 0 to 3 (grade
0 = absence, no synovial ﬂow; grade 1 = mild, less than or
equal to 3 isolated signals; grade 2 = moderate, more than
three isolated signals or conﬂuent signals in less than half of
the synovial area; grade 3 = marked, signals in more than half
of the synovial area); these scores corresponded to the maxi-
mum score for PD signals obtained from any of the synovial
sites evaluated at each joint, as documented by Naredo et al
[19]. Also, the sum of the PD signals scores obtained at each
joint was used as the PDUS scores. We have chosen eight
synovial sites from eight joints, including bilateral wrists (dor-
sal recess), elbows, ankles and knee joints. The eight-joint (8j)
PDUS score was the sum of the eight synovial sites [20].
The images were evaluated with the sequence and name of
the patient ‘‘blinded’’. The synovium was noted as non-in-
ﬂamed when no pixels were present in the ROI [21].
2.4. The Health Assessment Questionnaire (HAQ) score
It assessed the ability to perform 20 activities of daily living
[22], with four response categories. HAQ score, was a well
evaluated instrument for the assessment of personal activity
[23]. The Arabic version of HAQ score was validated for use
in RA [24].
Statistical analysis: Results were collected, tabulated, statis-
tically analysed by IBM personal computer and statistical
package SPSS version 16. Two types of statistics were done;
descriptive, e.g., no, percentage (%), mean, standard deviation
(SD) and range; and analytical, which included the following
tests. Student’s t-test, was used to collectively indicate the
presence of any signiﬁcant difference between two groups fora normally distributed quantitative variable. Fisher’s exact
test, was used to compare between two groups or more regard-
ing one qualitative variable in 2 · 2 contingency table when the
count of any of the expected cells less than 5. Pearson’s corre-
lation analysis, was used to show strength and direction of
association between two quantitative variables. P-value, was
considered non-signiﬁcant if p> 0.05, signiﬁcant difference
if p< 0.05, and highly signiﬁcant if p< 0.01 or p< 0.001.
3. Results
There was no signiﬁcant difference between the studied RA
and control groups regarding age and sex (p= 0.861 and
p= 0.288, respectively). Serum Ang-2 levels were signiﬁcantly
higher among patients (3191.3 ± 594.9 pg/ml) than controls
(1771.7 ± 103.1 pg/ml) (p< 0.001).
Clinical and laboratory characteristics of RA patients are
given in Table 1. Correlation between Ang-2 and clinical,
and laboratory data of RA patients, was shown in Table 2.
Correlation between serum angiopoietin-2 and DAS 28 to
Doppler ultrasound synovial thickness and score, for different
joints among rheumatoid arthritis patients, is shown in
Table 3.
Fig. 1, shows colour Doppler US of the right knee with four
hot spots and synovial Doppler score equal to 2. In contrast,
Fig. 2, shows colour Doppler US of the left wrist with synovial
thickness equal to 5.6 mm, active pannus and ﬁve hot spots,
with synovial Doppler score equal to 2.
4. Discussion
In our work, we noted an increase in the serum levels of Ang-2
in patients with RA, versus controls. This is compatible with
the results of previous studies [25,26]. Also, serum levels of
Ang-2 in patients with RA were positively correlated with
markers of inﬂammation (ESR, and CRP), and DAS28. This
is in accordance with recent studies [26,27]. In line with our
work, Kumpers et al. [28], reported that Ang-2 was elevated
in systemic lupus erythematosus patients with disease activity.
We noticed that Ang-2 levels were correlated with morning
stiffness, RF titre, but not with duration of RA, or patients’
age. Morning stiffness, which is characteristic of RA, usually
persists more than one hour but often lasts several hours. Its
duration is a useful gauge of the inﬂammatory activity of the
Figure 1 Colour Doppler ultrasound of the right knee showing
four hot spots with synovial Doppler score equal to 2.
Table 2 Correlation between serum angiopoietin-2 and clin-
ical, and laboratory data of rheumatoid arthritis patients.
Angiopoietin-2 (pg/ml)
r P value
Age (years) 0.273 0.088(NS)
Disease duration (years) 0.210 0.193(NS)
Duration of MS (minutes) 0.354 0.025 (S)
Haemoglobin (g) 0.125 0.443(NS)
Leucocyte count (1000/ml) 0.410 0.009(HS)
Platelet count (1000/ml) 0.242 0.133(NS)
ESR (mm/h) 0. 675 <0.001(HS)
CRP (mg/dl) 0.666 <0.001(HS)
RF titre (IU/ml) 0.462 0.003(HS)
VAS (cm) 0.252 0.117(NS)
DAS 28 0.624 <0.001(HS)
HAQ 0.131 0.421(NS)
MS=Morning stiffness, ESR= Erythrocyte sedimentation rate,
CRP= C-reactive protein, RF = Rheumatoid factor, VAS = Vi-
sual analogue scale, DAS28 = Disease activity score, HAQ=
Health Assessment Questionnaire, NS = Non-signiﬁcant,
S = Signiﬁcant, HS = Highly signiﬁcant.
Figure 2 Colour Doppler ultrasound of the left wrist showing
synovial thickness equal to 5.6 mm with active pannus and ﬁve hot
spots synovial Doppler score equal to 2.
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inﬂammatory markers and DAS28, are expected to correlate
with morning stiffness duration. Contrary to our work, Westra
et al. [26], found that Ang-2 levels were correlated positively
with age. This difference may be due to difference in patient’s
characteristics such as age limits.
The ﬁnding that Ang-2 was correlated with leucocytes
count is interesting. Ang-2 was considered to be a chronic
inﬂammatory mediator [30]. It was reported that the activated
synoviocytes-derived Ang-2 might play an important role in
RA pathogenesis through promoting synovial inﬂammation
[27].
In our work, Ang-2 was found to be not correlated with
HAQ score. This may be due to the characteristic of Ang-2
which acts as an inﬂammatory mediator [29], but not related
to personal activity.
We found a positive correlation between Ang-2 levels, and
synovial thickness as well as most joint signal scores. This is inTable 3 Correlation between serum angiopoietin-2 and DAS28 to
joints among rheumatoid arthritis patients.
Angiopoietin-2
r P
Synovial thickness (mm):
Wrist joints 0.593 <
Elbow joints 0.294 0
Ankle joints 0.556 <
Knee joints 0.634 <
Synovial signal score:
Wrist joints 0.504 <
Elbow joints 0.050 0
Ankle joints 0.659 <
Knee joints 0.882 <
Total signal score (TSS) 0.882 <
DAS28 = Disease activity score, NS=Non-signiﬁcant, S= Signiﬁcant,agreement with the ﬁndings of similar studies [19,31], who re-
ported that the TSS correlated with the level of Ang-2. The
synovium is normally a relatively acellular structure with a del-
icate intimal lining. In contrast, the RA synovium is greatly ex-Doppler ultrasound synovial thickness and score, for different
DAS28
value r P value
0.001 (HS) 0.139 0.393(NS)
.065 (NS) 0.254 0.114(NS)
0.001 (HS) 0.020 0.903(NS)
0.001 (HS) 0.359 0.023(S)
0.001 (HS) 0.525 0.001(HS)
.758 (NS) 0.241 0.134(NS)
0.001 (HS) 0.483 0.002(S)
0.001 (HS) 0.509 0.001(HS)
0.001 (HS) 0.195 0.228(NS)
HS=Highly signiﬁcant.
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matory hematopoietic lineage cells but also vascular endothe-
lial cells, exist in the RA synovium [32,33].
The increase in synovial blood ﬂow signals has been ob-
served histologically to be caused by an increase in the number
of blood vessels in the synovial tissue, i.e., angiogenesis [34,35].
Increased blood ﬂow signals on power Doppler US in the pro-
liferated synovium (pannus) of patients with RA have been
used to evaluate articular inﬂammation [36,37].
We assessed TSS in eight joints for every patient. However,
other studies used different numbers of joints. Actually,
Doppler US has been regarded as a valuable tool for globally
examining the extent of synovitis in RA. However, it is pres-
ently difﬁcult to determine a minimal number of joints to be
included in a global US score. There was a lack of clear deﬁni-
tion of synovitis as well as varying validity data with respect to
the proposed scores. So, scoring systems included a wide range
and number of joints [20,38]. Till present, further studies are
required in order to achieve optimal US scoring systems for
monitoring patients with RA in clinical trials and in clinical
practice [39].
Implications of the study. Firstly, the identiﬁcation of
markers for disease activity in patients with RA is crucial.
Ang-2 reﬂects the degree of inﬂammation in patients with
RA. Furthermore, it might predict disease outcomes. Its use
in everyday practice might help to identify the subset of pa-
tients who require aggressive treatment [40,41]. Secondly,
using power Doppler US, might not only help to identify
and monitor patients but also might provide an early assess-
ment of the response to a speciﬁc drug treatment. In the future,
the development of standard criteria will enable the wide-
spread use of this method in individual patients seen in every-
day clinical practice [8,42]. Finally, medications which
speciﬁcally target angiogenesis have produced promising re-
sults in other ﬁelds. Their use in the treatment of RA will prob-
ably be considered in the near future, although adjustments for
the speciﬁc features of RA will be needed. Angiogenesis mark-
ers can be expected to identify those patients most likely to
beneﬁt from anti-angiogenesis treatment options [4].
In conclusion, patients with RA had signiﬁcantly higher
levels of serum Ang-2 versus controls. In those patients, serum
Ang-2 levels were signiﬁcantly correlated with disease activity
markers, DAS28, duration of morning stiffness, but not pa-
tients’ age, duration of RA, or HAQ scores. Moreover, these
levels were signiﬁcantly correlated with US ﬁndings, namely
joint synovial thickness, and TSS. Therefore, serum Ang-2
levels might be used as a useful clinical biomarker for RA
activity.
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